摘要 |
The invention relates to a pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative and a cyclodextrin derivative of formula wherein R1a-g, R2a-g and R3a-g independently represent OH or O(CH2)4SO3H or a pharmaceutically acceptable salt thereof. |